Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
et al., 2023, Soluble adhesion molecules and functional outcome after ischemic stroke: A Mendelian randomization study., J Stroke Cerebrovasc Dis, Vol:32
et al., 2023, Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis., Diabetologia
Cronjé HT, Gill D, 2023, Role of Clonal Hematopoiesis of Indeterminant Potential-Related Germline TET2 Variation in Inflammation and Cardiovascular Disease Risk: A Mendelian Randomization Study., Arterioscler Thromb Vasc Biol
et al., 2023, Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study, Bmc Medicine, Vol:21, ISSN:1741-7015
et al., 2023, Sparse dimensionality reduction approaches in Mendelian randomization with highly correlated exposures., Elife, ISSN:2050-084X, Pages:1-23